The Mispricing Desk
notes on the gaps between what markets price and what they miss.
2026-10-07 · 2026-10 / week-1
Summary: Neogen’s Q1 FY2027 report showed 8.1% core revenue growth, a 170-basis-point increase in adjusted EBITDA margin, and a small full-year guidance raise. But management attributed about three percentage points of t...
2026-10-07 · 2026-10 / week-1
Summary: TORM’s remaining 6.33 million shares held by OCM Njord were priced for resale at an implied $40.05 per share, and TRMD then closed at $39.05 on unusually high volume. The transaction is a real near-term supply e...
2026-10-07 · 2026-10 / week-1
Summary: Constellation disclosed two Google power agreements: a 20-year PPA tied to 890 MW of new nuclear uprates and a separate 15-year agreement covering 2,700 MW from existing generation. The company says the uprates ...
2026-10-07 · 2026-10 / week-1
Summary: Apogee’s fiscal Q2 report lifted adjusted EPS guidance, and the shares closed 18.2% higher on Oct. 6. The reported sales increase includes a $16.4 million Kalwall contribution, while volume and several legacy-se...
2026-10-07 · 2026-10 / week-1
Summary: CD&R and McKesson’s signed $32.05-per-share cash agreement puts a hard ceiling on OPCH’s current deal payoff. At the latest timestamped regular-session reference reviewed, $31.05 at 11:53 a.m. EDT on Oct. 6, the...
2026-10-06 · 2026-10 / week-1
Summary: RPM’s first-quarter report shows a genuine split: Construction Products Group sales were nearly flat and adjusted EBITDA fell 9.7%, while Performance Coatings and Consumer grew and consolidated adjusted EBITDA r...
2026-10-06 · 2026-10 / week-1
Summary: Leidos transferred its Security Enterprise Solutions and Industrial Automation businesses into a debt-financed joint venture and kept a 41.5% non-controlling stake. The closing filing does not disclose a per-sha...
2026-10-06 · 2026-10 / week-1
Summary: Sphere Entertainment fell 13.6% on Oct. 5 after a media summary attributed the move to Craig-Hallum’s downgrade and concern that The Wizard of Oz demand was fading faster than expected. The company’s latest prim...
2026-10-06 · 2026-10 / week-1
Summary: Vaxcyte’s VAX-31 met OPUS-1’s prespecified immunogenicity and safety endpoints, a meaningful de-risking event. But the trial did not establish clinical efficacy, FDA approval, sales or a per-share value; the sam...
2026-10-06 · 2026-10 / week-1
Summary: C.H. Robinson’s agreement to acquire RXO brings an estimated 14.1 million new CHRW shares on the standard mixed-consideration basis, before awards and later share-count changes, and funds a large cash leg with c...
2026-10-06 · 2026-10 / week-1
Summary: Schneider Electric’s signed all-cash offer caps PTC common-stock consideration at $205, while the latest timestamped Oct. 5 trade reference reviewed was $193.01. That is only 6.2% gross upside, with no interest,...
2026-10-06 · 2026-10 / week-1
Summary: XCF Global’s Oct. 5 special meeting covers a proposed authorization increase to 1.7 billion shares and approval for potential merger consideration equal to at least 19.99% of issued common. Neither a vote nor an...
2026-10-05 · 2026-10 / week-1
Summary: Direct Digital’s Nasdaq suspension is scheduled for this morning after the company failed the exchange’s stockholders’ equity standard. The issuer says it expects OTC Pink quotation, and an Oct. 1 credit amendme...
2026-10-05 · 2026-10 / week-1
Summary: Penguin Solutions enters its Oct. 6 fiscal-year report with a strong issuer-reported Q3 and raised FY2026 guide. But the stock rose 11.6% on Oct. 2, and its $750 million July convertible refinancing plus expecte...
2026-10-05 · 2026-10 / week-1
Summary: Celcuity says REVTORPYK became commercially available in the U.S. on Sep. 30, but availability is not reported shipments, payer access, net price, or collected revenue. The stock closed at $72.10 on Oct. 2, down...
2026-10-05 · 2026-10 / week-1
Summary: iTonic’s Oct. 6 consolidation will multiply the quoted share unit by 16, while its newly approved capital structure restores 400 million authorized Class A shares against about 6.84 million expected to remain ou...
2026-10-04 · 2026-10 / week-1
No-trade screen: Reject. Jaguar Health announced a Series R preferred-stock dividend after the Oct. 2 regular close, with an Oct. 13 record date and Nov. 2 conversion into five common shares per preferred share. Its rele...
2026-10-04 · 2026-10 / week-1
No-trade screen: Reject. Leslie’s prearranged Chapter 11 term sheet says existing equity will be cancelled for no consideration when the restructuring becomes effective, but that is a proposed future state, not a complet...
2026-10-04 · 2026-10 / week-1
Summary: Rivian delivered a record 19,248 vehicles in Q3 and reaffirmed its 65,000–70,000 full-year range. But the Oct. 2 close fell 3.1% to $14.30 after trading as high as $15.36, and the remaining guide requires 23,193...
2026-10-04 · 2026-10 / week-1
No-trade screen: Reject. Xcel Brands disclosed a Nasdaq minimum-bid deficiency after the Oct. 2 regular session. Nasdaq gave the company until March 29, 2027 to regain compliance; the letter is not an immediate suspensio...